RecruitingNot ApplicableNCT07061730

Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production

Genesis: Clinical Trial of Better Speech's Artificial Intelligence Helper for Speech Therapy


Sponsor

Syracuse University

Enrollment

120 participants

Start Date

May 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research study is to evaluate the effectiveness of a hybrid Artificial Intelligence-assisted speech therapy model, which combines the use of an AI speech therapist (Jessica) with traditional speech therapy sessions led by a Speech-Language Pathologist (SLP). This study aims to determine whether the hybrid model improves articulation in children more effectively than traditional SLP-only therapy. Over the course of 8 weeks, participants will receive weekly therapy sessions, and those in the hybrid therapy group will also practice with Jessica between sessions. The study will also gather feedback from parents and speech therapists to assess their experiences and satisfaction with treatment.


Eligibility

Min Age: 5 YearsMax Age: 17 Years

Inclusion Criteria9

  • \- Response to be filled out by the Parent after sign up.
  • Does the child speak American English as one of their primary languages: Yes
  • At what age did the child first begin to learn English? Age 4 or younger
  • Child's current age: \> 5 years or \< 17 years 8 months
  • Does the child have any known history of any of the following: autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke: NO
  • Does the child have a diagnosis of ADD/ADHD, Tourette's Syndrome, or OCD? NO
  • Does the child currently have orthodontic appliances that block the roof of the mouth (e.g., palate expanders)? NO
  • Does the child currently have a cleft palate, fluency disorder (e.g., stuttering), or voice disorder? NO
  • Is one of your goals for your child to work on saying the "r" or "s" sounds? YES

Exclusion Criteria9

  • EXCLUSIONARY Response to be filled out by the Parent after sign up.
  • Does the child speak American English as one of their primary languages: No
  • At what age did the child first begin to learn English? Age 4 or older
  • Child's current age: \<5 years or \> 17 years 8 months
  • Does the child have any known history of any of the following: autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke: YES
  • Does the child have a diagnosis of ADD/ADHD, Tourette's Syndrome, or OCD? YES
  • Does the child currently have orthodontic appliances that block the roof of the mouth (e.g., palate expanders)? YES
  • Does the child currently have a cleft palate, fluency disorder (e.g., stuttering), or voice disorder? YES
  • Is one of your goals for your child to work on saying the "r" or "s" sounds? NO

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTraditional Therapy

The child would receive standard speech therapy, meeting with the SLP once a week for therapy sessions for 8 weeks. These sessions will focus on articulation practice, where your child will work on speech sounds with direct feedback from the SLP.

BEHAVIORALHybrid therapy

The child would receive standard speech therapy, meeting with the SLP once a week for therapy sessions for 8 weeks. These sessions will focus on articulation practice, where your child will work on speech sounds with direct feedback from the SLP. In addition to these weekly sessions, the child will practice using the AI-based speech therapy tool, Jessica, at home between sessions for 60 minutes per week. The tool will provide real-time feedback on the child's articulation and track their progress. The child will be asked to practice specific speech exercises, such as producing target sounds (e.g., /r/, /s/) in words, phrases, or sentences.


Locations(1)

Syracuse University

Syracuse, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07061730


Related Trials